• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Interactions of platelets with standard heparin and low molecular weight fractions.

作者信息

Dunn F W, Soria C, Thomaidis A, Soria J, Dupuy E, Bellucci S, Tobelem G

出版信息

Nouv Rev Fr Hematol (1978). 1984;26(4):249-53.

PMID:6089103
Abstract

The availability of fibrinogen receptors on platelets after ADP stimulation, was investigated in order to analyze platelet hyperaggregability induced by heparin. Unfractionated heparin increased the binding of fibrinogen on ADP-treated platelets. The results varied according to both the donor platelets and the kind of heparin preparation used. Beef lung heparin was more active than porcine intestinal mucosa heparin (P less than 0.001). Low molecular weight (LMW) heparin fractions however did not significantly increase the binding of fibrinogen to ADP-treated platelets. The effect of standard heparin and LMW heparin on the aggregation of normal platelets induced by the addition of plasma from patients with heparin-induced immune thrombocytopenia was also studied. Concerning heparin-induced immune thrombocytopenia we have shown that the plasma cofactor present in some patient plasma may induce platelet aggregation both in the presence of standard-heparin and in the presence of LMW heparin fractions. Therefore, one has to be careful when replacing standard heparin by LMW heparin or heparinoids since each patient may react differently.

摘要

相似文献

1
Interactions of platelets with standard heparin and low molecular weight fractions.
Nouv Rev Fr Hematol (1978). 1984;26(4):249-53.
2
Interaction of heparinoids with platelets: comparison with heparin and low molecular weight heparins.类肝素与血小板的相互作用:与肝素和低分子量肝素的比较。
Semin Thromb Hemost. 1991;17 Suppl 1:57-9.
3
Identification of human platelet membrane fibrinogen receptors by immunochemical techniques.通过免疫化学技术鉴定人血小板膜纤维蛋白原受体
Haematologia (Budap). 1984;17(3):387-98.
4
Comparison of the effects of unfractionated heparin and the low-molecular-weight heparins dalteparin and enoxaparin on spontaneous platelet aggregation and adenosine diphosphate activity in platelets during the third trimester of pregnancy.普通肝素与低分子量肝素达肝素和依诺肝素对妊娠晚期血小板自发聚集及血小板中腺苷二磷酸活性影响的比较。
Methods Find Exp Clin Pharmacol. 2007 Oct;29(8):539-45. doi: 10.1358/mf.2007.29.8.1116308.
5
Binding of fibrinogen to ADP-treated platelets. Comparison of plasma fibrinogen fractions and early plasmic fibrinogen derivatives.
J Lab Clin Med. 1983 Mar;101(3):453-60.
6
Effect of recombinant-tissue plasminogen activator, low molecular weight urokinase and unfractionated heparin on platelet aggregation.重组组织型纤溶酶原激活剂、低分子量尿激酶和普通肝素对血小板聚集的影响。
J Med. 1993;24(2-3):113-30.
7
Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin.在人全血中,肝素对血小板聚集的增强作用可被P2Y12和P2Y拮抗剂减弱,但阿司匹林无此作用。
Thromb Res. 2005;115(4):301-7. doi: 10.1016/j.thromres.2004.09.004.
8
Effect of heparin and heparin fractions on platelet aggregation.
J Clin Invest. 1980 Jan;65(1):64-73. doi: 10.1172/JCI109661.
9
Heparin-induced thrombocytopenia platelet aggregation studies in the presence of heparin fractions or semi-synthetic analogues of various molecular weights and anticoagulant activities.在存在各种分子量和抗凝活性的肝素片段或半合成类似物的情况下进行肝素诱导的血小板减少症血小板聚集研究。
Thromb Haemost. 1986 Feb 28;55(1):90-3.
10
Fibrinogen binding on human platelets. Influence of different heparins and of pentosane polysulfate.纤维蛋白原与人类血小板的结合。不同肝素和戊聚糖多硫酸盐的影响。
Thromb Res. 1983 Jan 15;29(2):141-8. doi: 10.1016/0049-3848(83)90135-4.

引用本文的文献

1
High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation.携带 V617F 突变的原发性血小板增多症患者肝素诱导的血小板减少症伴血栓形成的高发率。
J Thromb Thrombolysis. 2018 Jan;45(1):106-113. doi: 10.1007/s11239-017-1566-1.
2
Interaction of a new low molecular weight heparin (OP/LMWH) with human platelets.一种新型低分子量肝素(OP/LMWH)与人血小板的相互作用。
Agents Actions. 1986 Mar;17(5-6):512-4. doi: 10.1007/BF01965523.
3
[Ambulatory long-term prevention of thromboembolism with low-molecular weight heparin].
Klin Wochenschr. 1987 Apr 1;65(7):331-7. doi: 10.1007/BF01745389.